Citations 184
Therapy-Related Myelodysplastic Syndromes with Isolated Del(5q): Comparative Analysis of Phenotype and Long-Term Survival
Fleti, Farah, Singh, Amritpal , Al‐Kali, Aref , Foran, James M. , Elliott, Michelle A. , Begna, Kebede H. , Khera, Nandita , Abdelmagid, Maymona, Reichard, Kaaren K. , Pardanani, Animesh , Gangat, Naseema , Tefferi, Ayalew , Badar, Talha , Shah, Meera , Alkhateeb, Hassan B. , Ketterling, Rhett P.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6940-6941
Predictors of Response to Venetoclax Plus Hypomethylating Agent Therapy and Survival in Blast-Phase Myeloproliferative Neoplasm
Gangat, Naseema , Ilyas, Rimal, Begna, Kebede H. , Al‐Kali, Aref , Patnaik, Mrinal M. , Litzow, Mark R. , Mangaonkar, Abhishek A. , Elliott, Michelle A. , Foran, James M. , Palmer, Jeanne , Hanson, Curtis A. , Pardanani, Animesh , Tefferi, Ayalew , McCullough, Kristen , Hogan, William J. , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9675-9676
Clinical and Genetic Characteristics of STAG2 Mutations in Myeloid Neoplasms
Katamesh, Bahga , Nanaa, Ahmad , He, Rong , Viswanatha, David S., Nguyen, Phuong L., Bessonen, Kurt, Gangat, Naseema , Begna, Kebede H. , Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Litzow, Mark R. , Foran, James M. , Al‐Kali, Aref , Greipp, Patricia T. , Hogan, William J. , Shah, Meera , Yi, Cecilia Arana , Badar, Talha , Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12353-12354
Outcomes of Adults Treated with a Hypomethylating Agent Plus Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia: A Multicenter Retrospective Study
Geramita, Emily , Bastacky, Melissa, Cohen, Jessica B, Shallis, Rory M. , Litzow, Mark R. , Im, Annie , Wang, Hong , Bastacky, Melissa L. , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6187-6188
Differential Impact on Survival in Myeloid Neoplasm Patients with U2AF1 Mutations
Vanegas, Yenny Moreno , Nanaa, Ahmad , Al‐Kali, Aref , He, Rong , Patnaik, Mrinal M. , Gangat, Naseema , Litzow, Mark R. , Tefferi, Ayalew , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9602-9603
Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)
Ghorab, Ahmad , Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Tefferi, Ayalew , Begna, Kebede H. , Patnaik, Mrinal M. , Foran, James M. , Ghorab, Ahmad , Shah, Meera , Murthy, Hemant S. , Alkhateeb, Hassan B. , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9019-9020
The Characteristics and Prognosis of Patients with Clonal Cytopenias of Undetermined Significance, Including Cancer and Therapy-Related Clonal Cytopenias
Smith, Alexandra N., Ali, Najla Al , Coombs, Catherine C. , Foran, James M. , Tsai, Charlton , Amanam, Idoroenyi , Lai, Catherine , Deeg, Joachim, Dinner, Shira, Chandhok, Namrata S. , Soong, Deborah, Brunner, Andrew M. , Geyer, Susan M. , Padron, Eric , Patnaik, Mrinal M. , Al‐Kali, Aref , Xie, Zhuoer , Komrokji, Rami S. , Patel, Anand , Saygin, Caner , Zeidan, Amer M. , Bewersdorf, Jan Philipp , Kishtagari, Ashwin , Zeidner, Joshua F. , Madanat, Yazan F. , Badar, Talha , Desai, Pinkal , Griffiths, Elizabeth A. , Malki, Monzr M. Al , Lai, Catherine, Adès, Lionel , Yi, Cecilia Arana , Osman, Afaf E.G. , Abaza, Yasmin , Taylor, Justin , Carraway, Hetty E. , Singh, Abhay , Savona, Michael R.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2887-2890
U2AF1 Mutant Clonal Hematopoiesis Is Infrequent, Context Dependent, and Commonly Co-Occurs with BCOR Mutations
Pritzl, Stephanie , Lasho, Terra, Finke, Christy M. , Mangaonkar, Abhishek A. , Gangat, Naseema , Al‐Kali, Aref , Viswanatha, David S., He, Rong, Foran, James M. , Patnaik, Mrinal M. , Badar, Talha , Ferrer, Alejandro , McCullough, Kristen , Fernandez, Jenna , He, Rong
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11408-11409
Predictors of Long-Term Outcome in TP53-Mutated Acute Myeloid Leukemia Patients Receiving Allogeneic Stem Cell Transplant after First- or Second-Line Therapy: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Shallis, Rory M. , Stahl, Maximilian , Grenet, Justin , Palmisiano, Neil , Kubiak, Michal , Dinner, Shira, Litzow, Mark R. , Badar, Talha , Atallah, Ehab , Saliba, Antoine N. , Bewersdorf, Jan Philipp , Patel, Anand , Abaza, Yasmin , Murthy, Guru Subramanian Guru , DuVall, Adam , Burkart, Madelyn , Kota, Vamsi , Goldberg, Aaron D.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1435-1437
Clinical and Molecular Characteristics of ETV6 Mutated Myeloid Malignancies
Chekkaf, Ismahene, He, Rong , Viswanatha, David S., Mangaonkar, Abhishek A. , Begna, Kebede, Gangat, Naseema , Patnaik, Mrinal M. , Litzow, Mark R. , Foran, James M. , Al‐Kali, Aref , Gurney, Mark E. , Greipp, Patricia T. , Badar, Talha , Shah, Meera , Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6912-6914